| Market Capitalization (Millions $) |
3 |
| Shares
Outstanding (Millions) |
18 |
| Employees |
268 |
| Revenues (TTM) (Millions $) |
21 |
| Net Income (TTM) (Millions $) |
-26 |
| Cash Flow (TTM) (Millions $) |
-2 |
| Capital Exp. (TTM) (Millions $) |
7 |
Business Description
Vivos Therapeutics Inc is a medical technology company that specializes in treating obstructive sleep apnea (OSA) and other sleep-disordered breathing conditions. The company has developed a unique treatment approach called the Vivos System, which focuses on non-surgical, non-pharmaceutical methods to address the underlying causes of sleep apnea.
The Vivos System aims to remodel and enhance the patient's upper airway through the use of proprietary oral appliances. These appliances are custom-designed based on each individual's unique anatomy and are intended to widen the upper airway, leading to improved breathing during sleep.
The company's treatment approach is grounded in the concept of craniofacial growth and development, recognizing that deficiencies in facial and airway structures can contribute to sleep-disordered breathing. By utilizing a multidisciplinary approach involving dentists, orthodontists, and physicians, Vivos Therapeutics seeks to provide a comprehensive treatment solution for patients with sleep apnea.
Vivos Therapeutics Inc aims to address the significant unmet need for alternative treatments to the standard continuous positive airway pressure (CPAP) therapy, which can be cumbersome and uncomfortable for some patients. The company's technology has shown promise in clinical studies, with patients reporting significant improvements in sleep quality and reduction in sleep apnea symptoms.
In summary, Vivos Therapeutics Inc is a medical technology company that offers a unique non-surgical treatment approach for obstructive sleep apnea, focusing on enhancing the upper airway through custom-designed oral appliances.
Company Address: 7921 Southpark Plaza Littleton 80120 CO
Company Phone Number: 908-4867 Stock Exchange / Ticker: NASDAQ VVOS
|
54.24 %